Correlation Between Fate Therapeutics and In8bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and In8bio Inc, you can compare the effects of market volatilities on Fate Therapeutics and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and In8bio.

Diversification Opportunities for Fate Therapeutics and In8bio

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Fate and In8bio is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and In8bio go up and down completely randomly.

Pair Corralation between Fate Therapeutics and In8bio

Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the In8bio. In addition to that, Fate Therapeutics is 1.06 times more volatile than In8bio Inc. It trades about -0.17 of its total potential returns per unit of risk. In8bio Inc is currently generating about -0.07 per unit of volatility. If you would invest  30.00  in In8bio Inc on September 24, 2024 and sell it today you would lose (5.00) from holding In8bio Inc or give up 16.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fate Therapeutics  vs.  In8bio Inc

 Performance 
       Timeline  
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
In8bio Inc 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in In8bio Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, In8bio sustained solid returns over the last few months and may actually be approaching a breakup point.

Fate Therapeutics and In8bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fate Therapeutics and In8bio

The main advantage of trading using opposite Fate Therapeutics and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.
The idea behind Fate Therapeutics and In8bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum